Do you know how to avoid being perceived as an 'ugly foreigner' when working in Japan? Does the idea of going to Japan on business create anxiety or sleepless nights? Do you worry about committing a faux pas – perhaps without even knowing – that could cast you and your company in an unflattering light? If so, this presentation is for you.

This audio conference discusses in detail everything you need to know related to the social, cultural and business issues you might encounter while working in Japan. Attendees benefit from the perspective of a road warrior who has traveled to Japan dozens of times over the past 23 years, and has spent up to 100 days a year in-country while working for a major international pharmaceutical company and as an independent entrepreneur.

This audio conference covers:

The DOs and DON'Ts for conducting oneself while doing business in Japan, including:

• General: gift giving, transportation, hotels, tipping
• Social: relationships and networks, discrimination, dinner, nommunication
• Cultural: Western influences, women in the workforce, young vs. old, acceptance of cultural differences
• Business: agenda, business cards, bowing, seating, meeting conduct, communication

About the speaker:

Keith B. Russell, President and CEO of Global Pharmaceutical Services Inc. (GPSI), has been in the pharmaceutical industry for approximately 38 years, working for a large multinational company for 24 years and owning his own company for 14 years. To date, Keith has made approximately 80 trips to Japan sicne his first trip in 1987. He has worked in both the pre-clinical and clinical development arenas. During his clinical tenure, Keith served as the Scientific Liaison for The Upjohn Company in a licensing arrangement with Taisho Pharmaceutical Company. From 1992 to 1996, Keith was a member of the clinical development management team of Upjohn Japan in Tokyo, during which time the company submitted seven NDA submissions to the Ministry of Health, Labor and Welfare (MHLW).

Since forming his own company in 1996, Keith has provided consulting support in regulatory and clinical development matters to both domestic and international companies. In the spring of 2002, Keith was the primary author of a book entitled “New Drug Approval Process in Japan”. He also has written or contributed to articles that have appeared in various publications including The Scientist and R&D Directions. Keith has formed business partnerships with companies in Japan and India that offer extensive development and support services to clients wishing to conduct pre -clinical or clinical activities in these regions of the world.

Who should attend?

• Regulatory Affairs
• Clinical Operations
• Business Development
• Marketing
• Anyone with occasion to travel to Japan on business